News for ADMA Biologics, Inc. (ADMA)

At current levels, GRFS scores over ADMA with cheaper valuation, a broad portfolio, and strong EPS growth estimates despite the latter's robust Asceniv-driven momentum.

ADMA Biologics Inc showcases robust revenue growth and improved net income.Strategic expansion in biomanufacturing and plasma collection strengthens market pos

ADMA Biologics has surged 1,314% since 2021 with soaring revenue, ASCENIV demand, and strong financials. Learn why ADMA stock is a buy.

On May 8, 2025, Raymond James maintained its "Strong Buy" rating for ADMA Biologics (ADMA) while raising the price target significantly. The updated price targe

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Thursday. The Dow traded up 1.50% to 41,729.20 while the...

ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ETCompany ParticipantsSkyler Bloom - Senior Director, Business...

Market Analysis by covering: S&P 500, ADMA Biologics Inc, Penumbra Inc, TransMedics Group Inc. Read 's Market Analysis on Investing.com

Zacks.com users have recently been watching Adma Biologics (ADMA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Conference Call Scheduled for May 7, 2025, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. ( ADMA

PALM BEACH, Fla., April 29, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to reports from industry insiders the Global AI in Diabetic Re

ADMA Biologics receives FDA approval, boosting production by 20% and driving growth into late 2025. Analysts forecast a modest upside potential for the

We recently published an article titled Why Traders Flocked to These 10 Stocks on Monday. In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against the ...

Key Highlights: ADMA Biologics sees strategic interest from Caligan Partners, boosting its takeover potential. 37 hedge funds are currently invested in A

As of midday Monday, April 28, 2025, U.S. markets are showing mixed performance with the Dow Jones Industrial Average leading gains. The Dow is up

U.S. stocks were mostly higher, with the Dow Jones index gaining around 200 points on Monday. Shares of CEMEX, S.A.B. de C.V. CX rose sharply during Monday's s...

ADMA Biologics (ADMA) has secured approval from the U.S. Food and Drug Administration for its advanced yield enhancement production process. This new method is

Summary ADMA Biologics Inc (ADMA), a U.S.-based biopharmaceutical company, announced on April 28, 2025, that it has received U.S. FDA approval for its innovativ

The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

We recently published a list of 10 Firms End Stronger on Tuesday. In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against other firms that end stronger on Tuesday. A muted trading persisted on the stock market on Tuesday, with major indices ending in the red, recording minimal […]